PharmacoEconomics & Outcomes News 804, p24 - 2 Jun 2018 Osteoarthritis associated with high OOP costs in South Korea Osteoarthritis (OA) appears to be associated with catastrophic health expenditure (CHE) in households in South Korea (out-of-pocket [OOP] costs greater than 10%–40% of a household’s spending capacity), according to findings of a study published in the Journal of Korean Medical Science. Data from the 2013 Korea Health Panel Survey were used to estimate annual living expenses and OOP payments in households. Multivariable logistic analysis was used to investigate the impact of osteoarthritis on CHE; OOP payments of households with patients with osteoarthritis were compared with those in matched households with patients without osteoarthritis but with another chronic disease (cerebrovascular disease, diabetes mellitus, heart disease, hypertension, neoplasm or osteoporosis). 1289 households in each group were included in the study. Mean annual OOP payments were higher in households with than without osteoarthritis patients ($2789 vs $2607). Significantly more households with than without osteoarthritis patients had CHE at OOP thresholds of 10%, 20%, 30% and 40% (p<0.001). Osteoarthritis in a household significantly increased the risk of CHE at OOP thresholds of 10% (odds ratio [OR] 1.48; 95% CI 1.16, 1.87), 20% (OR 1.29; 95% CI 1.01, 1.66) and 30% (OR 1.37; 95% CI 1.05, 1.78), but had no significant effect on the risk of CHE at a threshold of 40% (OR 1.17; 95% CI 0.87, 1.57). "The OOP costs of hospitalization and drug use were higher in the households with OA patients than in those without OA patients," said the authors. "Policy makers should consider the economic burden of OA in the real world and investigate how to reduce extra medical costs incurred by OA patients under the current health care system," they said. Kim H, et al. Impact of Osteoarthritis on Household Catastrophic Health Expenditures in Korea. Journal of Korean Medical Science 33: e161, No. 21, 12 May 2018. Available from: URL: http://doi.org/10.3346/ jkms.2018.33.e161 803324251 1173-5503/18/0804-0001/$14.95 Adis © 2018 Springer International Publishing AG. All rights reserved PharmacoEconomics & Outcomes News 2 Jun 2018 No. 804
PharmacoEconomics & Outcomes News – Springer Journals
Published: Jun 2, 2018
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera